Annual long term liabilities:
$392.65M+$133.13M(+51.30%)Summary
- As of today (May 29, 2025), ASND annual total long term liabilities is $392.65 million, with the most recent change of +$133.13 million (+51.30%) on December 31, 2024.
- During the last 3 years, ASND annual long term liabilities has risen by +$278.37 million (+243.60%).
- ASND annual long term liabilities is now at all-time high.
Performance
ASND Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$395.85M+$3.20M(+0.82%)Summary
- As of today (May 29, 2025), ASND quarterly total long term liabilities is $395.85 million, with the most recent change of +$3.20 million (+0.82%) on March 31, 2025.
- Over the past year, ASND quarterly long term liabilities has increased by +$134.82 million (+51.65%).
- ASND quarterly long term liabilities is now -49.04% below its all-time high of $776.82 million, reached on September 30, 2023.
Performance
ASND quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ASND Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +51.3% | +51.6% |
| 3 y3 years | +243.6% | -41.8% |
| 5 y5 years | +1008.3% | +1066.8% |
ASND Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +243.6% | -49.0% | +236.8% |
| 5 y | 5-year | at high | +1008.3% | -49.0% | +1109.8% |
| alltime | all time | at high | >+9999.0% | -49.0% | >+9999.0% |
ASND Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $395.85M(+0.8%) |
| Dec 2024 | $392.65M(+51.3%) | $392.65M(-0.3%) |
| Sep 2024 | - | $393.87M(+58.6%) |
| Jun 2024 | - | $248.35M(-4.9%) |
| Mar 2024 | - | $261.02M(+0.6%) |
| Dec 2023 | $259.52M(+120.8%) | $259.52M(-66.6%) |
| Sep 2023 | - | $776.82M(+26.1%) |
| Jun 2023 | - | $615.86M(-6.0%) |
| Mar 2023 | - | $655.04M(+457.2%) |
| Dec 2022 | $117.55M(+2.9%) | $117.55M(-82.4%) |
| Sep 2022 | - | $667.41M(+5.8%) |
| Jun 2022 | - | $630.79M(-7.2%) |
| Mar 2022 | - | $679.81M(+494.9%) |
| Dec 2021 | $114.28M(+5.2%) | $114.28M(+3.1%) |
| Sep 2021 | - | $110.83M(-1.0%) |
| Jun 2021 | - | $111.93M(+6.6%) |
| Mar 2021 | - | $105.00M(-3.3%) |
| Dec 2020 | $108.58M(+206.5%) | $108.58M(+207.1%) |
| Sep 2020 | - | $35.35M(+8.1%) |
| Jun 2020 | - | $32.72M(-3.6%) |
| Mar 2020 | - | $33.93M(-4.2%) |
| Dec 2019 | $35.43M | $35.43M(+2.8%) |
| Sep 2019 | - | $34.47M(-3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $35.77M(+141.1%) |
| Mar 2019 | - | $14.84M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00 |
| Dec 2012 | $0.00(-100.0%) | - |
| Dec 2011 | $275.90K | - |
FAQ
- What is Ascendis Pharma A/S annual total long term liabilities?
- What is the all time high annual long term liabilities for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual long term liabilities year-on-year change?
- What is Ascendis Pharma A/S quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly long term liabilities year-on-year change?
What is Ascendis Pharma A/S annual total long term liabilities?
The current annual long term liabilities of ASND is $392.65M
What is the all time high annual long term liabilities for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual total long term liabilities is $392.65M
What is Ascendis Pharma A/S annual long term liabilities year-on-year change?
Over the past year, ASND annual total long term liabilities has changed by +$133.13M (+51.30%)
What is Ascendis Pharma A/S quarterly total long term liabilities?
The current quarterly long term liabilities of ASND is $395.85M
What is the all time high quarterly long term liabilities for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly total long term liabilities is $776.82M
What is Ascendis Pharma A/S quarterly long term liabilities year-on-year change?
Over the past year, ASND quarterly total long term liabilities has changed by +$134.82M (+51.65%)